Articles

Variable outcome and methylation status according to CEBPA mutant type in double-mutated acute myeloid leukemia patients and the possible implications for treatment

Department of Haematology, UCL Cancer Institute, London
MRC Human Genetics Unit and Edinburgh Cancer Research Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh
Department of Haematology, UCL Cancer Institute, London
Medical Genomics, UCL Cancer Institute, London
Centre for Trials Research, Cardiff University, UK
Centre for Trials Research, Cardiff University, UK
Department of Haematology, UCL Cancer Institute, London
Department of Haematology, UCL Cancer Institute, London
Vol. 103 No. 1 (2018): January, 2018 https://doi.org/10.3324/haematol.2017.173096